Employed in conventional Chinese, Ayurvedic, and Thai drugs. Conolidine could depict the start of a new era of Continual pain management. It is currently being investigated for its results to the atypical chemokine receptor (ACK3). Inside a rat product, it had been located that a competitor molecule binding to ACKR3 resulted in inhibition of ACKR3�